Marcus Lefebure, PhD

Roche Products Ltd.
Welwyn Garden City, United Kingdom

N/A

Presentation(s):

• (1550119) Final 7-year Follow Up and Retreatment Substudy Analysis of MURANO: Venetoclax-Rituximab-Treated Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

  Sunday, October 8, 2023
  3:05 PM – 3:10 PM EDT